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The aim was to evaluate the differences of mortality among asthma and COPD patients on the basis of the first 
period of hospitalization of these diseases. A total of 576 916 treatment periods for asthma and COPD between 1972 
and 1992 were identified in the discharge register maintained by the National Research and Development Centre for 
Welfare and Health. Patients aged 50-54 years first treated in hospital in 1977 or later were analysed. There were 
6655 new asthma patients of this age, 2727 new COPD patients and 701 new patients in a mixed group (with both 
diagnoses). Mortality up to the end of 1993 was analysed based on mortality and cause of death data provided by 
the Central Statistical Office of Finland. Estimated cumulative survival after 10 yr was higher among the asthma 
patients (83.5% for men and 93.2% for women) and lower among the COPD patients (60.1% and 78.0%) and in the 
mixed group (62.5% and 74.4%). The main cause of death among the asthmatics was asthma in 12.1% of cases, that 
among the COPD patients was COPD in 22.1% of cases and that in the mixed group was one or other of these 
diseases in 39.1% of cases. The prognosis for COPD patients aged 50-54 years requiring hospital treatment is poor. 
Combination of the data available from the cause of death and hospital discharge registers indicates that obstructive 
pulmonary diseases may well be of more significance from a public health point of view than the mortality statistics 
would lead us to believe. The very first hospitalization for COPD calls for a thorough evaluation of the prospects 
for active treatment and prevention. 
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Introduction 
The increasing prevalence of asthma, the resulting increased 
use of hospital services by asthma patients and the costs of 
such treatment are nowadays recognized as being of econ- 
omic significance on a national scale (1). Asthma is 
regarded especially as a disease affecting the younger age 
bracket in the population, and the current philosophy is 
that it should be treated at the earliest possible stage (2). 
Chronic obstructive pulmonary disease (COPD), on the 
other hand, is common among the older sectors of the 
population and those who smoke, giving rise to notable 
amounts of absence from work and premature retirement 
and increasing morbidity and mortality from other diseases 
(3). COPD patients are usually admitted to hospital only 
when the disease has reached an advanced stage, so that no 
effective medication is available and long periods have to be 
spent in hospital (4). 
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In the present situation in which all forms of health care 
are being subjected to stringent cost analysis, it is interest- 
ing to examine how much significance can be assigned to 
the differential diagnosis of asthma, a disease which is 
amenable to treatment, and COPD, which is commonly 
regarded as resistant to treatment. The purpose of the 
present investigation was thus to combine data extractable 
from the national hospital discharge and cause of death 
registers for Finland, a country with a population of 
approx. 5 million, in order to assess the prognosis for 50-54 
year old patients hospitalized for the first time for asthma 
or COPD. 
Subjects and Methods 
The National Research and Development Centre for Wel- 
fare and Health is provided with registration data on all 
patients treated in hospitals in Finland, including their 
diagnoses. All treatment periods for which the primary 
diagnosis was asthma or COPD were collected from the 
register (International Classification of Diseases, Eighth 
and Ninth Revision, rubeics 491-493 and 496). A total of 
576 9 16 such periods were recorded between 1972 and 1992. 
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Any patient who had had no recorded asthma-related 
hospital treatment (diagnosis 493) between 1972 and 1976 
and was first treated in hospital in 1977 or later and had no 
COPD-related hospital treatment (diagnoses 491, 492 or 
496) between 1977 and 1992 was considered a new asthma 
patient. These numbered 77 674. Likewise, any patient who 
had had no recorded COPD-related hospital treatment 
between 1972 and 1976 and was first treated in hospital in 
1977 or later and had no asthma-related hospital treatment 
between 1977 and 1992 was considered a new COPD 
patient. These numbered 40 580. There were also 6554 
patients who had had no asthma- or COPD-related hospital 
treatment between 1972 and 1976 and were first treated in 
hospital in 1977 or later, but who had more than one period 
of hospital treatment so that both asthma and COPD were 
recorded as main diagnoses on discharge, and these were 
placed in a mixed group of new patients. The year of 
discharge was taken as the index year. 
Patients in the age group from 50 to 54 years were 
analysed. Age was calculated as of the day of first admis- 
sion, which was also used in the survival analysis. There 
were 6655 new asthma patients, 2727 new COPD patients 
and 701 new patients in the mixed group in this age group. 
Mortality up to end of 1993 was ascertained from data 
provided by the Central Statistical Office of Finland. 
Kaplan-Meier survival analysis was used, the differences 
in survival functions between groups being assessed with 
the log rank test. The cross-tabulation data for the groups 
and diagnoses as indicated on the death certificates were 
tested with the Pearson x2 test. SPSS for Windows, release 
6.1, was used for the statistical calculations. 
Results 
SURVIVAL 
In the course of an average follow-up of 8.5 yr (SD 4.6 yr), 
19.0% of the patients had died. Survival was higher among 
the asthma patients and lower in the COPD and mixed 
groups (Table 1). 
The median survival time for all the COPD patients was 
14.5 yr [95% confidence interval (CI) 13.7-15.4 yr] and that 
for all the mixed group patients 14.1 yr (95% CI 12.7- 
15.6 yr). Of the asthmatics, 75% were still alive at the 
maximal survival time, which was limited to 17.7 yr. Men 
with COPD had the worst prognosis, with a median sur- 
vival time of 12.8 yr (95% CI 11.9-13.7 yr) (Figs 1 and 2). 
The asthma patients had a better prognosis than either 
the COPD patients or the mixed group (P=O.OOOO VS. both 
groups among both men and women), but there was no 
significant difference between the COPD patients and the 
mixed group in either the men (P=O.O756) or the women 
(P=O.O995). Women had a better prognosis than men in all 
three disease groups (P=O.OOOO, P=O.OOOO and P=O.O023, 
respectively). 
CAUSE OF DEATH 
Coronary heart disease was the most common main cause 
of death mentioned on the certificate (24.2%) of the study 
TABLE 1. Estimated cumulative 10 yr survival rates for 
hospitalized Finnish asthma, COPD and mixed group 
patients aged from 50 to 54 years, calculated from the time 
of first treatment in hospital 
No. 
of 
patients 
No. 
of 
deaths 
Survival (%) 
after 10 yr 
(standard error) 
Men 
Asthma 
COPD 
Mixed 
All 
2783 422 83.5 (0.9) 
2095 855 60.1 (1.2) 
480 194 62.5 (2.5) 
5358 1471 71.7 (0.7) 
Women 
Asthma 
COPD 
Mixed 
All 
3872 255 93.2 (0.5) 
632 118 78.0 (2.0) 
221 67 74.4 (3.3) 
4725 440 90.2 (0.5) 
All subjects 10 083 1911 80.2 (0.5) 
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FIG. 1. Comparison of survival rates for male Finnish 
asthma, COPD and mixed group patients aged from 50 to 
54 years. 
population, and was not unusual among the women (Table 
2), although it was more prevalent in the men (P=O.OOOO). 
COPD was the second commonest cause of death (17.4%) 
and was less frequent in the men, but the difference was not 
significant. Asthma accounted for 6.0% of all deaths of 
patients with obstructive pulmonary diseases, and was more 
widespread as a cause of death in the women (P=O.OOOO). 
Of the deaths in the asthma group, 12.1% had asthma as 
the main cause and 5.5% COPD, even though these patients 
had had no hospital admissions for COPD. Asthma was a 
rare cause of death in the COPD group, however, but 
COPD was common. The male COPD patients nevertheless 
had more cases of coronary ischaemia as the cause of death 
than of COPD. Although the mixed group contained 
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FIG. 2. Comparison of survival rates for female Finnish 
asthma, COPD and mixed group patients aged from 50 to 
54 years. 
patients with both diagnoses, COPD was almost four times 
more prevalent than asthma. 
Discussion 
The discharge register maintained by the National Research 
and Development Centre for Welfare and Health is an 
extensive one, covering all private, public, general and 
mental hospitals in Finland, and the correspondence 
between its diagnosis data and patient records has been 
found to be good (5). The diagnoses indicated in it are 
based on evaluations made by the doctors in the wards. The 
diagnoses quoted in the cause of death register are some- 
what less consistent, however, as death certificates are 
issued by specialists in different fields of medicine in differ- 
ent departments, home care situations and cases of accident 
or of death occurring at home, and in many instances by 
pathologists on the basis of autopsy findings (6). The 
clinician attending the patient during life is seldom 
the writer of the death certificate. Thus the diagnosis in the 
discharge register may correspond better to the actual 
nature of the disease. Since we have here a collection of 
data on a national scale covering a period of over 20 yr in 
which the same patients can be traced in the hospital 
discharge and cause of death registers by reference to their 
social security numbers, the results obtained can be said to 
be unique. 
The results indicate that the hospital doctors were gener- 
ally successful in distinguishing between asthma and COPD 
and underline the importance of their differential diagnosis. 
It is believed nowadays that treatment of asthma at an early 
stage can prevent it from developing into a chronic disease, 
obviate the need for hospital treatment and reduce the risk 
of death. They confirm earlier observations that persons 
suffering from asthma alone do not have such a high risk of 
death as COPD patients or persons with both conditions 
(7,8). If the patient has some other obstructive pulmonary 
disease in addition to asthma, however, the prognosis is not 
TABLE 2. Main causes of death (%) indicated on the death certificates of Finnish asthma, COPD and 
mixed group patients aged from 50 to 54 years after an average follow-up of 8.4 yr from the time of 
first treatment in hospital 
Men Women 
Diagnosis Asthma COPD Mixed Asthma COPD Mixed 
Asthma 10.4 0.8 6.2 14.9 2.6 14.9 
COPD 6.4 21.4 29.4 3.9 27.1 34.3 
Other pulmonary disease 0.9 3.5 2.1 1.2 2.6 3.0 
Pulmonary carcinoma 8.1 12.9 12.9 5.5 10.2 4.5 
Other tumours 10.0 7.8 9.3 25.1 10.2 1.5 
Coronary ischaemia 30.1 26.7 20.6 16.5 11.0 17.9 
Stroke 6.4 4.2 3.6 10.2 7.6 4.5 
Other circulatory diseases 7.8 7.3 5.1 8.2 7.6 4.5 
Violence or accident 12.6 7.6 7.2 6.3 4.2 1.5 
Other causes 7.3 7.8 3.6 8.2 16.9 13.4 
All diagnoses 100.0 100.0 100.0 100.0 100.0 100.0 
International classification of disease: asthma (493) COPD (491, 492 and 496), other pulmonary 
diseases (460-519, except 491493 and 496), pulmonary carcinoma (162) other tumours (140-239, 
except 162), coronary ischaemia (410-414), stroke (43@438), other circulatory diseases (390-459, 
except 410-414 and 430-438) violence or accident (E classification). 
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so good. COPD is a progressive disease for which there is 
no effective treatment, and it usually manifests itself in 
more elderly patients who have other complaints as well, 
which further detracts from the prognosis (4). Our present 
observations support earlier findings that indicate that 
COPD and asthma are separate diseases (89). 
It is essential to be aware of the practices involved in the 
assigning of causes of death in order to evaluate these 
causes and the resulting mortality statistics (10). The most 
common causes of death are the cardiovascular diseases 
that are so widespread among the Finns, because the last 
institution responsible for treating the patient will always 
seek to give a diagnosis that links the case with that 
institution and the last instance of treatment that the 
patient received and, since cardiovascular research has 
advanced further than that into pulmonary diseases, such 
causes of death are more easily accepted (11). The recording 
of cardiac deaths may also be explained by the fact that 
many patients may suffer from hypoxaemia in the stable 
phase of COPD, whereupon the risk of infarction during an 
exacerbation of the latter will increase as hypoxaemia 
becomes more serious. Hospital treatment for heart infarc- 
tion patients over 70 years of age becomes more compli- 
cated if they also have COPD, and mortality after discharge 
from hospital is higher (12). On the other hand, mortality 
also increases if asthma, chronic obstructive bronchitis, 
pneumonia or bronchitis is erroneously treated as cardiac 
insufficiency (13). 
Our present patients rarely had asthma as their cause of 
death even though they may previously have had periods of 
hospitalization for asthma, in spite of the fact that 
re-admissions for asthma entail a risk of death (14). The 
results support the notion that asthma is underrated as a 
cause of death in Finland. Mortality from asthma is low in 
this country (15), partly because treatment is still concen- 
trated in hospitals. Also, although asthma is very carefully 
defined as a cause of death among persons aged under 35 
years, it accounts for only about a third of the causes of 
death among asthmatics over this age (16). Elderly people, 
for instance, frequently have multiple diseases and a 
previous diagnosis of asthma is easily overlooked. 
The fact that mortality among men was higher than that 
among women in all the diagnostic groups is connected 
with the shorter mean life expectancy for men in Finland. 
Thus while the mean further expectation of life for 55 year 
old Finnish men in 1986 was 20.3 yr, the figure for women 
of the same age was 26.0 yr (17). It should be noted that 
smoking is more common among men than among women 
in this age group and that men have a higher incidence of 
COPD. It has also been shown that female asthmatics make 
more use of hospital services than do male asthmatics and 
that the men begin to use such services at a more advanced 
age (18). In the light of these observations, one is led to 
suspect that many of the male asthmatics are already in the 
chronic phase of the disease by the time they report for 
hospital treatment or that the asthma experienced by the 
men is a different disease, closer to COPD in character. 
Even so, obstructive pulmonary diseases are more easily 
accepted as causes of death for women, whereas cardiovas- 
cular diseases would appear to be the principal category for 
men, a trend possibly related to the popular concept of their 
widespread occurrence in the Finnish population. 
Obstructive pulmonary diseases may well be of consider- 
ably greater significance in public health terms than the 
register of causes of death would suggest. Certainly it can 
be shown by combining this register with the hospital 
discharge statistics that the prognosis for 50-54 year old 
COPD patients treated in hospital is poor, to the extent that 
only a half of them survive to reach retirement age. For this 
reason alone it is essential to consider all possibilities for 
active treatment and prevention when evaluating a patient 
who has been admitted to hospital for the first time with 
COPD. 
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